Tocotrienol-rich fraction (TRF) protects against retinal cell apoptosis and preserves visual behavior in rats with streptozotocin-induced diabetic retinopathy.
You GohMuhammad Zulfiqah SadikanHeethal JaiprakashNurul Alimah Abdul NasirRenu AgarwalIgor IezhitsaNafeeza Mohd IsmailPublished in: BMC complementary medicine and therapies (2024)
Oral TRF therapy for 12 weeks lowers retinal cell apoptosis by decreasing pro- and increasing anti-apoptotic markers. The preservation of visual behaviour in a two-chamber mirror test supported these retinal molecular alterations in diabetic rats.